Faqian Bu

530 total citations
14 papers, 366 citations indexed

About

Faqian Bu is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Faqian Bu has authored 14 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Organic Chemistry and 2 papers in Oncology. Recurrent topics in Faqian Bu's work include Melanoma and MAPK Pathways (5 papers), Histone Deacetylase Inhibitors Research (3 papers) and Synthesis of Tetrazole Derivatives (2 papers). Faqian Bu is often cited by papers focused on Melanoma and MAPK Pathways (5 papers), Histone Deacetylase Inhibitors Research (3 papers) and Synthesis of Tetrazole Derivatives (2 papers). Faqian Bu collaborates with scholars based in China and United States. Faqian Bu's co-authors include Guan Wang, Liang Ouyang, Shuai Wen, Yiwen Zhang, Aoxue Wang, Junping Pei, Yuxi Wang, Yumeng Zhu, Wěi Li and Duane D. Miller and has published in prestigious journals such as Angewandte Chemie International Edition, SHILAP Revista de lepidopterología and Chemical Communications.

In The Last Decade

Faqian Bu

13 papers receiving 363 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Faqian Bu China 9 218 115 64 33 29 14 366
Kazunobu Aoyama Japan 14 199 0.9× 42 0.4× 83 1.3× 41 1.2× 16 0.6× 19 409
Jun Yuan China 14 336 1.5× 91 0.8× 32 0.5× 32 1.0× 40 1.4× 28 654
Jaclyn R. Patterson United States 8 225 1.0× 71 0.6× 28 0.4× 12 0.4× 22 0.8× 9 360
Akiyoshi Tani Japan 13 234 1.1× 108 0.9× 122 1.9× 11 0.3× 16 0.6× 21 564
Susan Khan United States 11 199 0.9× 105 0.9× 31 0.5× 42 1.3× 20 0.7× 14 412
Hui Jie China 11 191 0.9× 86 0.7× 70 1.1× 10 0.3× 56 1.9× 17 371
Michał Załuski Poland 8 129 0.6× 41 0.4× 49 0.8× 18 0.5× 14 0.5× 12 295
Paride Liscio Italy 8 259 1.2× 36 0.3× 114 1.8× 83 2.5× 74 2.6× 11 543
Alexandra M. Fajardo United States 7 223 1.0× 42 0.4× 58 0.9× 8 0.2× 34 1.2× 12 345

Countries citing papers authored by Faqian Bu

Since Specialization
Citations

This map shows the geographic impact of Faqian Bu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Faqian Bu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Faqian Bu more than expected).

Fields of papers citing papers by Faqian Bu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Faqian Bu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Faqian Bu. The network helps show where Faqian Bu may publish in the future.

Co-authorship network of co-authors of Faqian Bu

This figure shows the co-authorship network connecting the top 25 collaborators of Faqian Bu. A scholar is included among the top collaborators of Faqian Bu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Faqian Bu. Faqian Bu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Wen, Shuai, Panpan Yang, Huan Xiao, et al.. (2024). Selective Covalent Inhibiting JNK3 by Small Molecules for Parkinson's Diseases. Angewandte Chemie International Edition. 63(50). e202411037–e202411037. 3 indexed citations
2.
3.
Wen, Shuai, Huan Xiao, Panpan Yang, et al.. (2024). Structure-Guided Discovery and Preclinical Assessment of Novel (Thiophen-3-yl)aminopyrimidine Derivatives as Potent ERK1/2 Inhibitors. Journal of Medicinal Chemistry. 67(8). 6425–6455. 4 indexed citations
4.
Lü, Yi, Faqian Bu, Fang Wang, et al.. (2023). Recent advances on the molecular mechanisms of exercise-induced improvements of cognitive dysfunction. Translational Neurodegeneration. 12(1). 9–9. 58 indexed citations
5.
6.
Wen, Shuai, Faqian Bu, Yumeng Zhu, et al.. (2023). Discovery of Novel Indazole Chemotypes as Isoform-Selective JNK3 Inhibitors for the Treatment of Parkinson’s Disease. Journal of Medicinal Chemistry. 66(2). 1273–1300. 10 indexed citations
7.
Pan, Xiaoli, Junping Pei, Aoxue Wang, et al.. (2022). Development of small molecule extracellular signal-regulated kinases (ERKs) inhibitors for cancer therapy. Acta Pharmaceutica Sinica B. 12(5). 2171–2192. 50 indexed citations
8.
Wang, Guan, Yongya Wu, Chengyong Wu, et al.. (2022). Rational design and crystallographic analysis of novel isoform-selective TRKA inhibitors for cancer therapy. Acta Pharmaceutica Sinica B. 13(1). 440–443. 4 indexed citations
9.
Zhu, Yumeng, Shuai Wen, Min Zhao, et al.. (2022). Unraveling the Design and Discovery of c-Jun N-Terminal Kinase Inhibitors and Their Therapeutic Potential in Human Diseases. Journal of Medicinal Chemistry. 65(5). 3758–3775. 18 indexed citations
10.
Wang, Guan, Jin Li, Xiaoli Pan, et al.. (2022). Discovery of Tyrosinase Inhibitors: Structure-Based Virtual Screening and Biological Evaluation. SHILAP Revista de lepidopterología. 4(1). e1–e8. 28 indexed citations
11.
Bu, Faqian, Jifa Zhang, Shuai Wen, et al.. (2021). Repurposing drugs in autophagy for the treatment of cancer: From bench to bedside. Drug Discovery Today. 27(7). 1815–1831. 14 indexed citations
12.
Bu, Faqian, Yuxi Wang, Fangyi Long, et al.. (2021). A Rationale for Drug Design Provided by Co-Crystal Structure of IC261 in Complex with Tubulin. Molecules. 26(4). 946–946. 4 indexed citations
13.
Pei, Junping, Xiaoli Pan, Aoxue Wang, et al.. (2021). Developing potent LC3-targeting AUTAC tools for protein degradation with selective autophagy. Chemical Communications. 57(97). 13194–13197. 60 indexed citations
14.
Wen, Shuai, Guan Wang, Yiwen Zhang, et al.. (2021). Recent Progress on Tubulin Inhibitors with Dual Targeting Capabilities for Cancer Therapy. Journal of Medicinal Chemistry. 64(12). 7963–7990. 104 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kazunobu Aoyama Breakdown of academic impact, for papers by Jun Yuan Breakdown of academic impact, for papers by Jaclyn R. Patterson Breakdown of academic impact, for papers by Akiyoshi Tani Breakdown of academic impact, for papers by Susan Khan Breakdown of academic impact, for papers by Hui Jie Breakdown of academic impact, for papers by Michał Załuski Breakdown of academic impact, for papers by Paride Liscio Breakdown of academic impact, for papers by Alexandra M. Fajardo
Rankless by CCL
2026